Patent · US Active

Salts of a compound and the crystalline forms thereof

US12084441B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Zhenping Wu · Shanghai, CN
Wenji Li · Shanghai, CN
Ling FENG · Shanghai, CN

Key dates

Filing date	Jun 21, 2022
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Jun 21, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C309/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine and the crystalline forms thereof, the solvates and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.